Koyfin Home > Directory > Health Care > Abeona Therapeutics > Preferred Equity

Abeona Therapeutics Preferred Equity Chart (ABEO)

Abeona Therapeutics annual/quarterly Preferred Equity from 2010 to 2014.
  • Abeona Therapeutics Preferred Equity for the quarter ending September 09, 2014 was $13m a 90.85% increase of 12m year over year
  • Abeona Therapeutics Preferred Equity for the last 12 months ending September 09, 2014 was $13m a 90.85% increase of 12m year over year
  • Abeona Therapeutics Annual Preferred Equity for 2013 was $1m a -673.11% decrease of -8m from 2012
  • Abeona Therapeutics Annual Preferred Equity for 2012 was $9m a 51.85% increase of 5m from 2011
  • Abeona Therapeutics Annual Preferred Equity for 2011 was $4m a -31.83% decrease of -1m from 2010
Other Balance Sheet Metrics:
  • Abeona Therapeutics Total Assets for the quarter ending September 09, 2018 was $161m a -11.33% decrease of -18m year over year
  • Abeona Therapeutics Other Liabilities for the quarter ending December 12, 2017 was $3m a -14.77% decrease of 0m year over year
  • Abeona Therapeutics Total Equity for the quarter ending September 09, 2018 was $150m a -13.21% decrease of -20m year over year
View Chart On Koyfin

Quarterly ABEO Preferred Equity Data

09/2014$13m
06/2014$12m
03/2014$1m
12/2013$1m
09/2013$1m
06/2013$1m
03/2013$4m
12/2012$9m
09/2012$30m
06/2012$16m

Annual ABEO Preferred Equity Data

2013$1m
2012$9m
2011$4m
2010$6m